Overview

Pharmacokinetic Study of Synera™ in Neonates and Infants

Status:
Suspended
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
This study will measure the amount of lidocaine and tetracaine in the blood after a 30 minute application of Synera.
Phase:
Phase 4
Details
Lead Sponsor:
ZARS Pharma Inc.
Treatments:
Lidocaine
Tetracaine